Calcium Channel Antagonists and Lactation: An Update

Journal of Human Lactation

Volumn 16, Issue 1, 2000, Pages 60-64

  Shannon, Meghan E ^a,b   Malecha, Susan E ^c   Cha, Amy J ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NONE

Author keywords

Breastfeeding; Calcium channel antagonist; Hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ADULT; BREAST FEEDING; CHEMISTRY; CHRONIC DISEASE; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; LACTATION; MIDDLE AGED; PREGNANCY; REVIEW;

ADULT; BREAST FEEDING; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; LACTATION; MIDDLE AGED; PREGNANCY;

EID: 0034139397     PISSN: 08903344     EISSN: None     Source Type: Journal    
DOI: 10.1177/089033440001600113     Document Type: Review

References (22)

1. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey III (NHANES III). American Heart Association and Stroke Facts, 1999.
2. Atkinson HC, Begg EJ, Darlow BA, Drugs in human milk. Clin Pharmacokinet. 1988;14:217-240.
3. Penny WJ, Lewis MJ. Nifedipine is excreted in human milk. Eur J Clin Pharmacol. 1989;36:427-428.
4. Ehrenkranz RA, Ackerman BA, Hulse JD. Nifedipine transfer into human milk. J Pediatr. 1989;114:478-480.
5. Manninen AK, Juhakoski A. Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. Int J Clin Pharmacol Res. 1991;11(5):231-236.
6. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and chemicals into human milk. Pediatrics. 1994;93:137-150.
7. Norvasc (Product insert). New York, NY: Pfizer, Inc; 1996.
8. White WB, Yeh SC, Krol GJ. Nitrendipine in human plasma and breast milk. Eur J Clin Pharmacol. 1989;36:531-534.
9. Carcas AJ, Abad-Santos F, de Rosendo JM, et al. Nimodipine transfer into human breast milk and cerebrospinal fluid. Ann Pharmacother. 1996;30:148-150.
10. Tonks AM. Nimodopine levels in breast milk. Aust N Z J Surg. 1995;65:694-695.
11. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Baltimore, Md: Lippincott Williams and Wilkins; 1998.
12. DynaCirc (Product insert). East Hanover, NJ: Novartis Pharmaceuticals Corporation; 1997.
13. Sular (Product insert). Wayne, Penn: Zeneca Pharmaceuticals; 1996.
14. Cardene (Product insert). Nutley, NJ: Roche Laboritories; 1996.
15. McAllister RG, Hamann SR, Blouin RA. Pharmacokinetics of calcium-entry antagonists. Am J Cardiol. 1985;55:30B-40B.
16. Andersen HJ. Excretion of verapamil in human milk. Eur J Clin Pharmacol. 1983;25:279-280.
17. Anderson P, Bondesson U, Mattiasson I, et al. Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur J Clin Pharmacol. 1987;31:625-627.
18. Miller MR, Withers R, Bharmra R, et al. Verapamil and breast feeding. Eur J Clin Pharmacol. 1986;30:125-126.
19. Inoue H, Unno N, Ou MC, et al. Level of verapamil in human milk. Eur J Clin Pharmacol. 1984;26:657-658.
20. Hartmann D, Lunell NO, Friedrich G, et al. Excretion of tiapamil in breast milk. Br J Clin Pharmacol. 1988;26:183-186.
21. Okada M, Inoue H, Nakamura H, et al. Excretion of diltiazem in human milk. N Engl J Med. 1985;312:992-993.
22. Vascor (Product insert). Raritan, NJ: Ortho McNeil; 1998.